PubMed:10216071
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-38 | protein | denotes | E2A-HLF chimeric protein |
| T2 | 144-163 | DNA | denotes | E2A-HLF fusion gene |
| T3 | 178-195 | DNA | denotes | t(17;19)(q22;p13) |
| T4 | 245-274 | protein | denotes | chimeric transcription factor |
| T5 | 288-312 | protein | denotes | trans-activating domains |
| T6 | 316-319 | protein | denotes | E2A |
| T7 | 337-373 | protein | denotes | DNA-binding and dimerization domains |
| T8 | 377-400 | protein | denotes | hepatic leukemic factor |
| T9 | 402-405 | protein | denotes | HLF |
| T10 | 484-491 | protein | denotes | E2A-HLF |
| T11 | 498-522 | DNA | denotes | Ig enhancer and promoter |
| T12 | 751-761 | cell_type | denotes | thymocytes |
| T13 | 815-825 | cell_type | denotes | thymocytes |
| T14 | 896-915 | cell_type | denotes | splenic lymphocytes |
| T15 | 1121-1128 | protein | denotes | E2A-HLF |
| T16 | 1505-1519 | cell_type | denotes | lymphoid cells |
| T17 | 1531-1538 | protein | denotes | E2A-HLF |
| T18 | 1601-1608 | protein | denotes | E2A-HLF |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-139 | Sentence | denotes | Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia. |
| S2 | 140-407 | Sentence | denotes | The E2A-HLF fusion gene, generated by t(17;19)(q22;p13) in acute lymphoblastic leukemia (ALL), encodes a chimeric transcription factor in which the trans-activating domains of E2A are fused to the DNA-binding and dimerization domains of hepatic leukemic factor (HLF). |
| S3 | 408-601 | Sentence | denotes | To investigate its biological role, we generated transgenic mice expressing E2A-HLF using Ig enhancer and promoter, which direct transgene expression in cells committed to the lymphoid lineage. |
| S4 | 602-712 | Sentence | denotes | The transgenic mice exhibited abnormal development in the thymus and spleen and were susceptible to infection. |
| S5 | 713-852 | Sentence | denotes | The thymus contained small numbers of thymocytes, and TUNEL staining showed that higher population of thymocytes were undergoing apoptosis. |
| S6 | 853-1072 | Sentence | denotes | The spleen exhibited a marked reduction in splenic lymphocytes and the flow cytometric analyses and the in vitro colony formation assays showed that the B-cell maturation was blocked at a very early developmental stage. |
| S7 | 1073-1283 | Sentence | denotes | These findings indicated that the expression of E2A-HLF induced T-cell apoptosis and B-cell maturation arrest in vivo and that the susceptibility of the transgenic mice to infection was due to immunodeficiency. |
| S8 | 1284-1539 | Sentence | denotes | Moreover, several transgenic mice developed acute leukemia, classified as T-ALL based on the surface marker analysis and DNA rearrangements, suggesting that an additional event is required for malignant transformation of lymphoid cells expressing E2A-HLF. |
| S9 | 1540-1669 | Sentence | denotes | Our findings provide insight into the biological function of E2A-HLF in lymphoid development and also its role in leukemogenesis. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 110-138 | NP | denotes | acute lymphoblastic leukemia |
| C2 | 140-163 | NP | denotes | The E2A-HLF fusion gene |
| C3 | 199-233 | NP | denotes | acute lymphoblastic leukemia (ALL) |
| C4 | 243-274 | NP | denotes | a chimeric transcription factor |
| C5 | 278-283 | NP | denotes | which |
| C6 | 423-426 | NP | denotes | its |
| C7 | 484-491 | NP | denotes | E2A-HLF |
| C8 | 498-522 | NP | denotes | Ig enhancer and promoter |
| C9 | 524-529 | NP | denotes | which |
| C10 | 602-621 | NP | denotes | The transgenic mice |
| C11 | 702-711 | NP | denotes | infection |
| C12 | 751-761 | NP | denotes | thymocytes |
| C13 | 815-825 | NP | denotes | thymocytes |
| C14 | 1073-1087 | NP | denotes | These findings |
| C15 | 1121-1128 | NP | denotes | E2A-HLF |
| C16 | 1222-1241 | NP | denotes | the transgenic mice |
| C17 | 1245-1254 | NP | denotes | infection |
| C18 | 1531-1538 | NP | denotes | E2A-HLF |
| C19 | 1540-1552 | NP | denotes | Our findings |
| C20 | 1601-1608 | NP | denotes | E2A-HLF |
| C21 | 1642-1645 | NP | denotes | its |
| R1 | C3 | C1 | coref-ident | acute lymphoblastic leukemia (ALL),acute lymphoblastic leukemia |
| R2 | C5 | C4 | coref-relat | which,a chimeric transcription factor |
| R3 | C6 | C2 | coref-pron | its,The E2A-HLF fusion gene |
| R4 | C9 | C8 | coref-relat | which,Ig enhancer and promoter |
| R5 | C13 | C12 | coref-ident | thymocytes,thymocytes |
| R6 | C15 | C7 | coref-ident | E2A-HLF,E2A-HLF |
| R7 | C16 | C10 | coref-ident | the transgenic mice,The transgenic mice |
| R8 | C17 | C11 | coref-ident | infection,infection |
| R9 | C18 | C15 | coref-ident | E2A-HLF,E2A-HLF |
| R10 | C19 | C14 | coref-ident | Our findings,These findings |
| R11 | C20 | C18 | coref-ident | E2A-HLF,E2A-HLF |
| R12 | C21 | C20 | coref-pron | its,E2A-HLF |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-38 | protein_molecule | denotes | E2A-HLF chimeric protein |
| T2 | 47-63 | other_name | denotes | T-cell apoptosis |
| T3 | 65-89 | other_name | denotes | B-cell maturation arrest |
| T4 | 110-138 | other_name | denotes | acute lymphoblastic leukemia |
| T5 | 144-163 | DNA_domain_or_region | denotes | E2A-HLF fusion gene |
| T6 | 178-195 | DNA_domain_or_region | denotes | t(17;19)(q22;p13) |
| T7 | 199-227 | other_name | denotes | acute lymphoblastic leukemia |
| T8 | 229-232 | other_name | denotes | ALL |
| T9 | 245-274 | protein_family_or_group | denotes | chimeric transcription factor |
| T10 | 288-312 | protein_domain_or_region | denotes | trans-activating domains |
| T11 | 316-319 | protein_molecule | denotes | E2A |
| T12 | 377-400 | protein_molecule | denotes | hepatic leukemic factor |
| T13 | 402-405 | protein_molecule | denotes | HLF |
| T14 | 457-472 | other_artificial_source | denotes | transgenic mice |
| T15 | 484-491 | protein_molecule | denotes | E2A-HLF |
| T16 | 606-621 | other_artificial_source | denotes | transgenic mice |
| T17 | 660-666 | body_part | denotes | thymus |
| T18 | 671-677 | body_part | denotes | spleen |
| T19 | 702-711 | other_name | denotes | infection |
| T20 | 717-723 | body_part | denotes | thymus |
| T21 | 751-761 | cell_type | denotes | thymocytes |
| T22 | 767-781 | other_name | denotes | TUNEL staining |
| T23 | 815-825 | cell_type | denotes | thymocytes |
| T24 | 842-851 | other_name | denotes | apoptosis |
| T25 | 857-863 | body_part | denotes | spleen |
| T26 | 896-915 | cell_type | denotes | splenic lymphocytes |
| T27 | 924-948 | other_name | denotes | flow cytometric analyses |
| T28 | 957-989 | other_name | denotes | in vitro colony formation assays |
| T29 | 1006-1023 | other_name | denotes | B-cell maturation |
| T30 | 1046-1071 | other_name | denotes | early developmental stage |
| T31 | 1121-1128 | protein_molecule | denotes | E2A-HLF |
| T32 | 1137-1143 | other_name | denotes | T-cell |
| T33 | 1144-1153 | other_name | denotes | apoptosis |
| T34 | 1165-1182 | other_name | denotes | maturation arrest |
| T35 | 1226-1241 | other_artificial_source | denotes | transgenic mice |
| T36 | 1245-1254 | other_name | denotes | infection |
| T37 | 1266-1282 | other_name | denotes | immunodeficiency |
| T38 | 1302-1317 | other_artificial_source | denotes | transgenic mice |
| T39 | 1328-1342 | other_name | denotes | acute leukemia |
| T40 | 1360-1363 | other_name | denotes | ALL |
| T41 | 1377-1400 | other_name | denotes | surface marker analysis |
| T42 | 1405-1423 | other_name | denotes | DNA rearrangements |
| T43 | 1477-1501 | other_name | denotes | malignant transformation |
| T44 | 1505-1519 | cell_type | denotes | lymphoid cells |
| T45 | 1531-1538 | protein_molecule | denotes | E2A-HLF |
| T46 | 1601-1608 | protein_molecule | denotes | E2A-HLF |
| T47 | 1612-1632 | other_name | denotes | lymphoid development |
| T48 | 1654-1668 | other_name | denotes | leukemogenesis |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 199-227 | HP_0006721 | denotes | acute lymphoblastic leukemia |
| T2 | 219-227 | HP_0001909 | denotes | leukemia |
| T3 | 687-711 | HP_0002719 | denotes | susceptible to infection |
| T4 | 1266-1282 | HP_0002721 | denotes | immunodeficiency |
| T5 | 1328-1342 | HP_0002488 | denotes | acute leukemia |
| T6 | 1334-1342 | HP_0001909 | denotes | leukemia |